These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21495291)

  • 1. [Recent advances in molecular pathogenesis and polycystic kidney disease treatment].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):13-22. PubMed ID: 21495291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):11-20. PubMed ID: 18677899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic kidney disease: the cilium as a common pathway in cystogenesis.
    Lina F; Satlinb LM
    Curr Opin Pediatr; 2004 Apr; 16(2):171-6. PubMed ID: 15021197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR signaling in polycystic kidney disease.
    Ibraghimov-Beskrovnaya O; Natoli TA
    Trends Mol Med; 2011 Nov; 17(11):625-33. PubMed ID: 21775207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic advances in the treatment of polycystic kidney disease.
    Riella C; Czarnecki PG; Steinman TI
    Nephron Clin Pract; 2014; 128(3-4):297-302. PubMed ID: 25573484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.
    Parker MI; Nikonova AS; Sun D; Golemis EA
    Cell Signal; 2020 Mar; 67():109497. PubMed ID: 31830556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
    Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative roles of cilia in polycystic kidney disease.
    Winyard P; Jenkins D
    Biochim Biophys Acta; 2011 Oct; 1812(10):1256-62. PubMed ID: 21586324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.
    Ibraghimov-Beskrovnaya O; Bukanov N
    Cell Mol Life Sci; 2008 Feb; 65(4):605-19. PubMed ID: 17975706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apico-basal polarity in polycystic kidney disease epithelia.
    Wilson PD
    Biochim Biophys Acta; 2011 Oct; 1812(10):1239-48. PubMed ID: 21658447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.
    Smith LA; Bukanov NO; Husson H; Russo RJ; Barry TC; Taylor AL; Beier DR; Ibraghimov-Beskrovnaya O
    J Am Soc Nephrol; 2006 Oct; 17(10):2821-31. PubMed ID: 16928806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic kidney disease and the renal cilium.
    Deane JA; Ricardo SD
    Nephrology (Carlton); 2007 Dec; 12(6):559-64. PubMed ID: 17995581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for human polycystic kidney disease.
    Nagao S; Kugita M; Yoshihara D; Yamaguchi T
    Exp Anim; 2012; 61(5):477-88. PubMed ID: 23095811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.
    Patel V; Li L; Cobo-Stark P; Shao X; Somlo S; Lin F; Igarashi P
    Hum Mol Genet; 2008 Jun; 17(11):1578-90. PubMed ID: 18263895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polycystic kidney disease: from genetics to dialysis].
    Ortiz Arduan A
    An R Acad Nac Med (Madr); 2012; 129(2):687-96; discussion 697-9. PubMed ID: 24298871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling.
    Hakim S; Dyson JM; Feeney SJ; Davies EM; Sriratana A; Koenig MN; Plotnikova OV; Smyth IM; Ricardo SD; Hobbs RM; Mitchell CA
    Hum Mol Genet; 2016 Jun; 25(11):2295-2313. PubMed ID: 27056978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease.
    Jo HS; Eum WS; Park EY; Ko JY; Kim DY; Kim DW; Shin MJ; Son O; Cho SB; Park JH; Lee CH; Yeo EJ; Yeo HJ; Choi YJ; Youn JK; Cho SW; Park J; Park JH; Choi SY
    BMB Rep; 2017 Sep; 50(9):460-465. PubMed ID: 28760196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-catenin ablation exacerbates polycystic kidney disease progression.
    Conduit SE; Hakim S; Feeney SJ; Ooms LM; Dyson JM; Abud HE; Mitchell CA
    Hum Mol Genet; 2019 Jan; 28(2):230-244. PubMed ID: 30265301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in polycystic kidney disease.
    Goilav B
    Biochim Biophys Acta; 2011 Oct; 1812(10):1272-80. PubMed ID: 21241798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.